Health CatalystHCAT
About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
Employees: 1,300
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
4,933% more call options, than puts
Call options by funds: $23.3M | Put options by funds: $463K
29% more capital invested
Capital invested by funds: $336M [Q2] → $434M (+$97.6M) [Q3]
4% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 24
2% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 50
0% more funds holding in top 10
Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]
1% less funds holding
Funds holding: 160 [Q2] → 159 (-1) [Q3]
0.9% less ownership
Funds ownership: 89.1% [Q2] → 88.2% (-0.9%) [Q3]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Wells Fargo Stan Berenshteyn 56% 1-year accuracy 5 / 9 met price target | 75%upside $10 | Overweight Maintained | 21 Jan 2025 |
Canaccord Genuity Richard Close 66% 1-year accuracy 19 / 29 met price target | 75%upside $10 | Buy Maintained | 21 Jan 2025 |
RBC Capital Sean Dodge 58% 1-year accuracy 26 / 45 met price target | 23%upside $7 | Sector Perform Maintained | 15 Jan 2025 |
Citigroup Daniel Grosslight 41% 1-year accuracy 9 / 22 met price target | 75%upside $10 | Buy Maintained | 10 Jan 2025 |
Keybanc Scott Schoenhaus 58% 1-year accuracy 21 / 36 met price target | 58%upside $9 | Overweight Upgraded | 8 Jan 2025 |
Financial journalist opinion
Based on 6 articles about HCAT published over the past 30 days









